349 related articles for article (PubMed ID: 37958980)
1. Application of Luteolin in Neoplasms and Nonneoplastic Diseases.
Rakoczy K; Kaczor J; Sołtyk A; Szymańska N; Stecko J; Sleziak J; Kulbacka J; Baczyńska D
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958980
[TBL] [Abstract][Full Text] [Related]
2. Luteolin, a flavonoid with potential for cancer prevention and therapy.
Lin Y; Shi R; Wang X; Shen HM
Curr Cancer Drug Targets; 2008 Nov; 8(7):634-46. PubMed ID: 18991571
[TBL] [Abstract][Full Text] [Related]
3. Multi-Faceted Role of Luteolin in Cancer Metastasis: EMT, Angiogenesis, ECM Degradation and Apoptosis.
Rocchetti MT; Bellanti F; Zadorozhna M; Fiocco D; Mangieri D
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240168
[TBL] [Abstract][Full Text] [Related]
4. Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review.
Pandurangan AK; Esa NM
Asian Pac J Cancer Prev; 2014; 15(14):5501-8. PubMed ID: 25081655
[TBL] [Abstract][Full Text] [Related]
5. From nature to therapy: Luteolin's potential as an immune system modulator in inflammatory disorders.
Hussain MS; Gupta G; Goyal A; Thapa R; Almalki WH; Kazmi I; Alzarea SI; Fuloria S; Meenakshi DU; Jakhmola V; Pandey M; Singh SK; Dua K
J Biochem Mol Toxicol; 2023 Nov; 37(11):e23482. PubMed ID: 37530602
[TBL] [Abstract][Full Text] [Related]
6. Targeting cell signaling and apoptotic pathways by luteolin: cardioprotective role in rat cardiomyocytes following ischemia/reperfusion.
Xu T; Li D; Jiang D
Nutrients; 2012 Dec; 4(12):2008-19. PubMed ID: 23235403
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer.
Naiki-Ito A; Naiki T; Kato H; Iida K; Etani T; Nagayasu Y; Suzuki S; Yamashita Y; Inaguma S; Onishi M; Tanaka Y; Yasui T; Takahashi S
Carcinogenesis; 2020 Aug; 41(8):1145-1157. PubMed ID: 31805186
[TBL] [Abstract][Full Text] [Related]
8. Molecular targets of luteolin in cancer.
Tuorkey MJ
Eur J Cancer Prev; 2016 Jan; 25(1):65-76. PubMed ID: 25714651
[TBL] [Abstract][Full Text] [Related]
9. Anti-carcinogenic effects of the flavonoid luteolin.
Seelinger G; Merfort I; Wölfle U; Schempp CM
Molecules; 2008 Oct; 13(10):2628-2651. PubMed ID: 18946424
[TBL] [Abstract][Full Text] [Related]
10. Luteolin, inflammation and cancer: Special emphasis on gut microbiota.
Franza L; Carusi V; Nucera E; Pandolfi F
Biofactors; 2021 Mar; 47(2):181-189. PubMed ID: 33507594
[TBL] [Abstract][Full Text] [Related]
11. Distribution and biological activities of the flavonoid luteolin.
López-Lázaro M
Mini Rev Med Chem; 2009 Jan; 9(1):31-59. PubMed ID: 19149659
[TBL] [Abstract][Full Text] [Related]
12. Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease.
Goyal A; Solanki K; Verma A
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23619. PubMed ID: 38091364
[TBL] [Abstract][Full Text] [Related]
13. Role of microRNAs in the anticancer effects of the flavonoid luteolin: a systematic review.
Mishan MA; Khazeei Tabari MA; Mahrooz A; Bagheri A
Eur J Cancer Prev; 2021 Sep; 30(5):413-421. PubMed ID: 33720053
[TBL] [Abstract][Full Text] [Related]
14. Pyrrolidine dithiocarbamate inhibition of luteolin-induced apoptosis through up-regulated phosphorylation of Akt and caspase-9 in human leukemia HL-60 cells.
Cheng AC; Huang TC; Lai CS; Kuo JM; Huang YT; Lo CY; Ho CT; Pan MH
J Agric Food Chem; 2006 Jun; 54(12):4215-21. PubMed ID: 16756349
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of metastasis suppression by luteolin in breast cancer.
Cook MT
Breast Cancer (Dove Med Press); 2018; 10():89-100. PubMed ID: 29928143
[TBL] [Abstract][Full Text] [Related]
16. Luteolin exhibits anti-breast cancer property through up-regulating miR-203.
Gao G; Ge R; Li Y; Liu S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3265-3271. PubMed ID: 31368817
[TBL] [Abstract][Full Text] [Related]
17. A superoxide-mediated mitogen-activated protein kinase phosphatase-1 degradation and c-Jun NH(2)-terminal kinase activation pathway for luteolin-induced lung cancer cytotoxicity.
Bai L; Xu X; Wang Q; Xu S; Ju W; Wang X; Chen W; He W; Tang H; Lin Y
Mol Pharmacol; 2012 Apr; 81(4):549-55. PubMed ID: 22222766
[TBL] [Abstract][Full Text] [Related]
18. Luteolin ameliorates DSS-induced colitis in mice via suppressing macrophage activation and chemotaxis.
Xue L; Jin X; Ji T; Li R; Zhuge X; Xu F; Quan Z; Tong H; Yu W
Int Immunopharmacol; 2023 Nov; 124(Pt B):110996. PubMed ID: 37776768
[TBL] [Abstract][Full Text] [Related]
19. Luteolin, a flavonoid, as an anticancer agent: A review.
Imran M; Rauf A; Abu-Izneid T; Nadeem M; Shariati MA; Khan IA; Imran A; Orhan IE; Rizwan M; Atif M; Gondal TA; Mubarak MS
Biomed Pharmacother; 2019 Apr; 112():108612. PubMed ID: 30798142
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant and antitumor efficacy of Luteolin, a dietary flavone on benzo(a)pyrene-induced experimental lung carcinogenesis.
Kasala ER; Bodduluru LN; Barua CC; Gogoi R
Biomed Pharmacother; 2016 Aug; 82():568-77. PubMed ID: 27470398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
